MRP ₹295
(Inclusive of all Taxes)
₹39.8 Cashback (14%)
Extra 15% Off with Bank Offers
coupon
Available Offers
APLICICISave 19% on medicine orders above Rs. 1999 with ICICI credit Card
ONECARD5Flat 5% off on non- medicine orders above Rs. 700 with OneCard
ONECARD18Flat 18% Off on medicine orders above Rs. 1250 with OneCard
APOLLOMOBIKWIKUpto Rs. 500 cashback on payments above Rs. 999 with Mobikwik Wallet
APLAZYPAYUpto Rs. 300 cashback on 1st transaction of Rs. 500 and above with LazyPay
Author Details
Drug-Drug Interactions
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
CLINDAMYCIN-1%W/VOther bacterial intestinal infections
Severe
CLINDAMYCIN-1%W/VDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
Drug-Diseases Interactions
Login/Sign Up
CLINDAMYCIN-1%W/VOther bacterial intestinal infections
Severe
How does the disease interact with Clindaily Topical Solution:
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
CLINDAMYCIN-1%W/VDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
How does the disease interact with Clindaily Topical Solution:
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
CLINDAMYCIN-1%W/VOther diseases of liver
Moderate
How does the disease interact with Clindaily Topical Solution:
The liver is the primary site of Clindaily Topical Solution metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Clindaily Topical Solution and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Clindaily Topical Solution therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Clindaily Topical Solution is primarily metabolized by the liver. Therapy with Clindaily Topical Solution should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
The liver is the primary site of Clindaily Topical Solution metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Clindaily Topical Solution and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Clindaily Topical Solution therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Clindaily Topical Solution is primarily metabolized by the liver. Therapy with Clindaily Topical Solution should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/VOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Clindaily Topical Solution:
Clindaily Topical Solution is partially removed by the kidney. Clindaily Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindaily Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindaily Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Clindaily Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Clindaily Topical Solution is partially removed by the kidney. Clindaily Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindaily Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindaily Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Clindaily Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/VOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Clindaily Topical Solution:
Clindaily Topical Solution is partially removed by the kidney. Clindaily Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindaily Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindaily Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Clindaily Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Clindaily Topical Solution is partially removed by the kidney. Clindaily Topical Solution should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindaily Topical Solution concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindaily Topical Solution should be administered cautiously in patients with severely impaired renal function. Serum Clindaily Topical Solution concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Author Details
Have a query?
